Meridian Bioscience Named Top Dividend Stock With Insider Buying And 4.52% Yield (VIVO)

In this series, we look through the most recent Dividend Channel ''DividendRank'' report, and then we cherry pick only those companies that have experienced insider buying within the past six months. The officers and directors of a company tend to have a unique insider's view of the business, and presumably the only reason an insider would choose to take their hard-earned cash and use it to buy stock in the open market, is that they expect to make money — maybe they find the stock very undervalued, or maybe they see exciting progress within the company, or maybe both. So when stocks turn up that see insider buying, and are also top ranked, investors are wise to take notice. One such company is Meridian Bioscience Inc. ( VIVO), which saw buying by Director Dwight E. Ellingwood.

The Top DividendRank'ed Stocks With Insider Buying »

Back on January 23, Ellingwood invested $35,125.99 into 1,980 shares of VIVO, for a cost per share of $17.74. In trading on Friday, bargain hunters could buy shares of Meridian Bioscience Inc. ( VIVO) and achieve a cost basis 0.8% cheaper than Ellingwood, with shares changing hands as low as $17.59 per share. It should be noted that Ellingwood has collected $0.40/share in dividends since the time of their purchase, so they are currently up 1.4% on their purchase from a total return basis. Meridian Bioscience Inc. shares are currently trading -0.11% on the day. The chart below shows the one year performance of VIVO shares, versus its 200 day moving average:

Meridian Bioscience Inc. Chart

Looking at the chart above, VIVO's low point in its 52 week range is $15.56 per share, with $21.33 as the 52 week high point — that compares with a last trade of $17.70. By comparison, below is a table showing the prices at which insider buying was recorded over the last six months:

If you liked this article you might like

3 Undiscovered, Undervalued Health Care Stocks Poised to Outperform the Sector in 2016

Insider Trading Alert - VIVO, CCG And PDCE Traded By Insiders

Meridian Bioscience (VIVO) Weak On High Volume

Buy These 4 High-Yield Dividend Stocks to Take Advantage of the Health Care Boom

Meridian Bioscience (VIVO) Upgraded From Hold to Buy